Innoviva Inc.

04/24/2024 | Press release | Distributed by Public on 04/24/2024 05:16

Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024